<p>C2C12 cells were treated with different concentrations of TGF-β1 for 96 hours and stained for nuclei and MHC. (A) Cell proliferation, as denoted by number of nuclei, increased in a dose-dependent manner with an EC50 for TGF-β1 of 17 pM. (B) Myoblast differentiation, as measured by percentage of nuclei positive for MHC, decreased with increasing concentrations of TGF-β1 with an IC50 of 23 pM.</p
FPTEC, HREC and HK-2 were seeded onto 96-well plates at sub-confluent density and proliferation asse...
<p>(A) Phase images are shown of ADSCs treated with TGF-β (TGF-β, 4d) or with bFGF (bFGF, 4d) for 4 ...
<p>(A) Immunofluorescence staining for nuclei and MRTF-A in TGFβ1-treated NMuMG cells cultured on 40...
<p>TGF-β1 (50 pM) was used to inhibit C2C12 differentiation. (A) Increasing concentrations of SB4315...
<p>(A) Smad2/3 nuclear localization (Ai, green) and <i>CXCR4</i> expression (Aii) in TGF-β-treated 6...
<p>Compounds tested for their ability to overcome the anti-myogenic effect of TGF-β1 in C2C12 cells....
<p>Vehicle control had no effect on C2C12 differentiation or cell proliferation (A and E) (scale bar...
<p>Subconfluent VSMCs were stimulated for 48(20 ng/mL, every 24 h) or TGFβ (1 ng/mL), alone or in co...
<p>(A) Left side: HCC cell lines were treated with 5 ng/ml TGF-β for indicated time points. Changes ...
<p>(A) Left side: HCC cell lines were treated with 5 ng/ml TGF-β for indicated time points. Changes ...
<p>Primary human osteoblasts were treated for 8 days with different conc. (0, 1, 2.5, 5, 10 ng/ml) o...
<p>(A) Representative histograms (n = 3) showing proliferation measured by CFSE staining of CD4<sup>...
<p>(a) Phase-contrast micrographs of NHU cell cultures at confluence following growth for 6 days in ...
<p><b>(A)</b> HL-60 cell proliferation in the presence of increasing concentrations of TGFβ alone (b...
<p>(A) C2C12 muscle cells were treated with TGF-β ligands for the time frames shown and then assesse...
FPTEC, HREC and HK-2 were seeded onto 96-well plates at sub-confluent density and proliferation asse...
<p>(A) Phase images are shown of ADSCs treated with TGF-β (TGF-β, 4d) or with bFGF (bFGF, 4d) for 4 ...
<p>(A) Immunofluorescence staining for nuclei and MRTF-A in TGFβ1-treated NMuMG cells cultured on 40...
<p>TGF-β1 (50 pM) was used to inhibit C2C12 differentiation. (A) Increasing concentrations of SB4315...
<p>(A) Smad2/3 nuclear localization (Ai, green) and <i>CXCR4</i> expression (Aii) in TGF-β-treated 6...
<p>Compounds tested for their ability to overcome the anti-myogenic effect of TGF-β1 in C2C12 cells....
<p>Vehicle control had no effect on C2C12 differentiation or cell proliferation (A and E) (scale bar...
<p>Subconfluent VSMCs were stimulated for 48(20 ng/mL, every 24 h) or TGFβ (1 ng/mL), alone or in co...
<p>(A) Left side: HCC cell lines were treated with 5 ng/ml TGF-β for indicated time points. Changes ...
<p>(A) Left side: HCC cell lines were treated with 5 ng/ml TGF-β for indicated time points. Changes ...
<p>Primary human osteoblasts were treated for 8 days with different conc. (0, 1, 2.5, 5, 10 ng/ml) o...
<p>(A) Representative histograms (n = 3) showing proliferation measured by CFSE staining of CD4<sup>...
<p>(a) Phase-contrast micrographs of NHU cell cultures at confluence following growth for 6 days in ...
<p><b>(A)</b> HL-60 cell proliferation in the presence of increasing concentrations of TGFβ alone (b...
<p>(A) C2C12 muscle cells were treated with TGF-β ligands for the time frames shown and then assesse...
FPTEC, HREC and HK-2 were seeded onto 96-well plates at sub-confluent density and proliferation asse...
<p>(A) Phase images are shown of ADSCs treated with TGF-β (TGF-β, 4d) or with bFGF (bFGF, 4d) for 4 ...
<p>(A) Immunofluorescence staining for nuclei and MRTF-A in TGFβ1-treated NMuMG cells cultured on 40...